Status:

COMPLETED

A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients

Lead Sponsor:

Yuhan Corporation

Conditions:

Respiratory Disease

Eligibility:

All Genders

15-74 years

Phase:

PHASE4

Brief Summary

This is a phase 4, randomized, double-blind, multicenter clinical trial to evaluate the efficacy and safety of YMC026 in respiratory disease patients with cough and sputum as the main symptoms

Detailed Description

The study has planned 4 visits during 2 weeks period (1 week of screening period, 1 week of treatment period). All subjects who agree to participate in the study and voluntarily give written informed ...

Eligibility Criteria

Inclusion

  • Both gender, 15 years ≤ age \< 75 years
  • Patients with BSS(Bronchitis Severity Score) ≥ 5point at screening visit and randomization visit
  • Written consent voluntarily to participate in this clinical trial

Exclusion

  • Patients with severe respiratory disease
  • Patients with severe pulmonary disease
  • Patients who has history for drug hypersensitivity or allergic reaction in component of investigational product or similar drug
  • Patients with pregnant and/or have breast feeding
  • Patients who were treated with monoamine oxidase inhibitor, antihistamines, anti-viral drugs and glucocorticoids within 2 weeks prior to administration of investigational product
  • Patients who were treated with β2-agonist and anticholinergic drug within 1 weeks prior to administration of investigational product
  • Patients who were treated with secretolytics, mucolytics and bronchodilators within 1 day prior to administration of investigational product
  • Patients who are participating in another trial within 30 days prior to screening visit
  • Patients who investigators determines not appropriate to take part in this clinical study

Key Trial Info

Start Date :

October 27 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2018

Estimated Enrollment :

223 Patients enrolled

Trial Details

Trial ID

NCT03334916

Start Date

October 27 2017

End Date

October 30 2018

Last Update

January 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Catholic University of Korea, Seoul St.Mary's Hospital

Seoul, South Korea